Genitourinary oncology is advancing fast. At the MOASC Spotlight on Oncology event on August 16, 2025, at VEA Newport Beach,…
Browsing: ASCO
Welcome to OncologyTube’s ASCO Page! Here, we deliver the latest videos, expert interviews, and key updates from the American Society of Clinical Oncology (ASCO). Dive into groundbreaking cancer research, treatment advancements, and highlights from ASCO annual meetings and symposiums—all tailored for healthcare professionals like you. Stay ahead with the most current oncology insights, brought to you directly from the heart of clinical progress!
The Camizestrant SERENA-6 trial shone at ASCO 2025, presented by Professor Nick Turner. This Phase 3 study targets ESR1-mutated, ER-positive,…
The Matterhorn Trial, a landmark phase III study published in the New England Journal of Medicine, evaluates durvalumab, an anti-PD-L1…
Welcome to this comprehensive web companion for the OncologyTube.com video, “HR+/HER2- metastatic breast cancer 2L outcomes: Top 10 from ASCO…
Introduction to HCC Treatment Insights Hepatocellular carcinoma (HCC) presents tough treatment challenges, requiring careful patient selection for local therapies. This…
Tarlatamab Phase 3 Results SCLC ASCO 2025 The tarlatamab phase 3 results for SCLC, shared at ASCO 2025, showed a…
Introduction to Pancreatic Cancer Treatment at ASCO 2025 At the ASCO 2025 Annual Meeting, Dr. Brian Wolpin presented groundbreaking updates…
At the 2025 ASCO Annual Meeting, new data on IO-based combinations in mRCC emerged. For instance, Dr. Brian Rini, MD…
Published: June 4, 2025Category: Lung Cancer Research Introduction to Neoadjuvant Nivolumab Plus Chemotherapy in CheckMate 816 The CheckMate 816 trial…
This video presents the myeloma treatment algorithm 2025 for transplant-ineligible patients, shared by Dr. Vincent Rajkumar at ASCO 2025. Designed…
At the 2025 ASCO Annual Meeting, a phase 3 randomized trial revealed that the timing of immunotherapy in non-small cell…
What’s New at ASCO 2025? The ASCO 2025 conference in Chicago brought exciting news for cancer care. A major study,…
ATOMIC Trial ASCO 2025: Key Results RevealedOn June 1, 2025, the ASCO Annual Meeting in Chicago presented the ATOMIC trial…
Introduction Cancer of Unknown Primary (CUP) diagnostics is a critical area for oncologists and researchers, as 2-5% of cancer cases…
Published: May 30, 2025 Pfizer shared results from the BRAFTOVI BREAKWATER trial at ASCO 2025. The trial tested BRAFTOVI® (encorafenib) with cetuximab…
Posted on May 30, 2025 by ASCO Editorial Team Artificial intelligence (AI) is reshaping the future of cancer research and…
The Top 10 GI Trials at ASCO 2025 are here (with Dates and Times), and OncologyTube proudly presents an exclusive…
OncologyTube.com presents the ASCO 2025 Top 10 Abstracts, highlighting practice-changing trials in oncology. It features advancements in cancer care, from…
The American Society of Clinical Oncology (ASCO) Annual Meeting is a pivotal event for oncology professionals, and ASCO 2025, happening…
Published: April 21, 2025 | OncologyTube.com A groundbreaking phase III study, published on April 11, 2025, in the Journal of…
The 2025 ASCO guidelines on sentinel lymph node biopsy (SLNB) for early-stage breast cancer are reshaping oncology care. Published in the Journal of Clinical Oncology, these recommendations, backed by extensive clinical trials, aim to reduce unnecessary procedures, lower costs, and address health disparities. Learn about the six key updates, their impact on patients, and how they promote personalized treatment while minimizing complications like lymphedema. Visit OncologyTube.com for more insights.
By Dr. Bradley McGregor | Published April 02, 2025 Renal cell cancer (RCC) treatment continues to evolve, and Tivozanib (TIVO)…
Extended CheckMate-274 Results Show Continued Benefit With Nivolumab in MIBC Date: February 14, 2025 Author: Dr. Matthew I. Milowsky, MD,…
Transforming MIBC Treatment: Insights from the NIAGARA Trial Posted on February 16, 2025 The landscape of treating muscle-invasive bladder cancer…
Talazoparib + Enzalutamide Introduction: We are excited to share the latest findings from the TALAPRO-2 Trial, which marks a significant…
Introduction: Recent data from the American Society of Clinical Oncology (ASCO) GI Cancers Symposium 2025, as detailed in their educational…
Abstract: Circulating tumor DNA (ctDNA) has a short half-life (<2 hours) which may permit real-time monitoring of tumor status. This…
In the rapidly evolving field of cancer treatment, the application of comprehensive genomic profiling (CGP) via liquid biopsy has become…
In the evolving landscape of cancer care In the evolving landscape of cancer care, the use of circulating tumor DNA…
In a recent interview with Dr. Ignacio Garrido-Laguna from the University of Utah Health, we gained fascinating insights into the…
In an enlightening discussion at the latest medical symposium, Dr. Jonathan Nowak, MD from Brigham and Women’s Hospital, shared critical…
By: Elizabeth Catherine Smyth – Cambridge University Hospitals NHS Foundation Trust Background: Oesophagogastric adenocarcinoma (OGA) remains a significant global health…
Background: The treatment landscape for well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has been slow to evolve, with limited evidence supporting the…
Introduction ASCO 2024 Head & Neck Cancer developments brought forth several anticipated studies. These studies in the field of head…
Author: Dr. Shubham Pant, MD – MD Anderson Overview: At the ASCO 2024 conference, Dr. Shubham Pant, MD – MD…
Author: Dr. Zandra Klippel, Global Product Head, Multiple Myeloma, Sanofi At the ASCO 2024 conference, Dr. Zandra Klippel the Global…
Author: Dr. Alexis LeVee, City of Hope At the ASCO 2024 conference, Dr. Alexis LeVee from City of Hope presented…
Author: Dr. Regina Barragan-Carillo, City of Hope Overview: At ASCO 2024, Dr. Regina Barragan-Carillo from City of Hope Cancer Center…
Presented by Dr. Hedyeh Ebrahimi, City of Hope Overview: At the ASCO 2024 conference, Dr. Hedyeh Ebrahimi of City of…
… Dr. Sumanta (Monty) Kumar Pal, M.D., FASCO highlights some of the top data and presentations being presented in kidney and…
Dr. Omid Hamid from The Angeles Clinic goes over his favorite presentations coming up at ASCO 2024. Should these be…
Howard S. Hochster, MD: [00:00:00] Um, first of all, this is for late line colorectal cancer after the standard chemotherapy…
OncologyTube: [00:00:00] Okay, we’re here at ASCO GI 2024 and we have Dr. Dr. Riccardo Lencioni, MD medical doctor, professor…
Jalen Patel, MD – City of Hopeaugust 21, 2023Drawing from data provided by ASCO and Friends of Cancer Research, the…
Akasha Dukkipati, MD at City of Hope August 21, 2023 Akasha Dukkipati, MD at City of Hope, conducted an analysis…
iFrame is not supported! Lung Cancer: My Top 5 Abstracts to See in Lung Cancer at ASCO 2023 Jack West…
Lung Cancer: My Top 5 Abstracts to See in Lung Cancer at ASCO 2023 By Jack West, MD, associate professor…
iFrame is not supported! Everolimus: Julie Gralow SABCS 2022 SWOG S1207 in HER2- Breast Cancer What is Everolimus and…
Everolimus: Julie Gralow SABCS 2022 SWOG S1207 in HER2- Breast Cancer What is Everolimus and how can it help…
ASCO [2022] Lung Cancer In-Depth Slides: MOASC Dr. Misako Nagasaka’s (thoracic oncology) MOASC Presentation on ASCO (Annual Meeting, American…
ASCO (American Society of Clinical Oncology) [2022] Sarcomas Cancer In-Depth Slides: MOASC Â Dr. Warren Chow’s MOASC Presentation on ASCO…
Question and Answer Session Joseph Chao, MD – ASCO 2022 Esophageal In-Depth Slides: MOASC Spotlight https://oncologytube.com/v/41288 Joseph Chao, MD -…
Question and Answer Session Arash Rezazadeh, MD, ASCO [2022] Genitourinary Cancer: MOASC Oncology Spotlight Link https://oncologytube.com/v/41291 Arash Rezazadeh, MD, ASCO…
ASCO [2022] Genitourinary Cancer(s): MOASC Oncology Spotlight Dr. Arash Rezazadeh’s MOASC 2022 Presentation in Genitourinary Cancers (ASCO genitourinary cancers symposium)…
ASCO 2022 Esophageal In-Depth Slides: MOASC Spotlight  ASCO 2022 Esophageal Cancer Abstracts Highlights Abstracts of interest that were recently…
ASCO 2022 Prostate Cancer Overview: MOASC Spotlight  ARASENS Trial I presented at MOASC three datasets in prostate cancer from…
Dr. Nan Chen from the University of Chicago Medicine shares a status update from ASCO on the quality improvement program…
Platinum Chemotherapy: vs. Temozolomide/Capecitabine for Advanced GEPNENs: ECOG-ACRIN EA2142 Results Jennifer Eads MD By Jennifer Eads, MD So, at ASCO…
Pathologic Complete Response: How may the I-SPY2 trial help HR positive HER2 negative Breast Cancer patients? Laura Huppert By Laura…
T-Vec: + Pembro Advanced Melanoma MASTERKEY-115 Trial Dr Gastman By Brian Gastman, MD The FDA’s approval of multiple drugs for…
KRAS Lung Cancer: Taking on Goliath Discussion by Jai Luo MD By Jai Luo, MD Hi there, my name is…
DCISionRT: Assessing Breast Cancer Adjuvant Endocrine Therapy After BCS Chirag Shah MD By Chirag Shah, MD So this study was…
CEACAM5: Safety and Efficacy Outcome in Long-term Treatment with SAR408701 in Pts with NSQ NSCLC Prof Charles Ricordel By Professor…